SYNACT (SYNACT) News
Track canonical SquawkNews coverage tagged to SYNACT, SYNACT. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
SynAct Pharma CEO and CSO sell shares
SynAct Pharma CEO and CSO sold shares, per TradingView News.
EQUITY | Sep 03, 2026, 05:33 AM UTC
L
SynAct Pharma to present resomelagon preclinical RA data in 2026
SynAct Pharma will present new resomelagon preclinical data on a Phase 3-ready RA therapeutic candidate at the 17th World Congress of Inflammation 2026.
GEOPOLITICS | Aug 28, 2026, 09:45 AM UTC